| Financial Year |
March 31 2023 |
| Monetary Funds |
2,073,709,319.40 |
| Held-for-trading Financial Assets |
2,862,287.01 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,007,534,793.69 |
| Advances to Suppliers |
202,303,623.64 |
| Other Receivables |
77,452,633.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,162,791,808.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
147,729,448.87 |
| Total Current Assets |
9,354,058,156.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
24,951,959.16 |
| Long-term Equity Investment |
20,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
4,296,854,584.12 |
| Under-construction Projects |
243,762,289.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,651,624,060.70 |
| R&D expenses |
157,069,132.87 |
| Goodwill |
1,589,580,436.48 |
| Long-Term Deferred and Prepaid Expenses |
227,231,822.16 |
| Deferred Income Tax Assets |
307,336,139.44 |
| Other Non-Current Assets |
12,078,596.53 |
| Sub-Total of Non-Current Assets |
8,702,327,619.42 |
| Total Assets |
18,056,385,776.22 |
| Short-Term Loans |
4,225,443,249.00 |
| Trading Financial liabilities |
393,185.63 |
| Notes Payable |
375,123,431.07 |
| Accounts Payable |
1,042,925,392.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
221,589,604.90 |
| Taxes Payable |
117,618,939.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
528,433,746.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
571,643,331.30 |
| Other Current Liabilities |
1,754,634.36 |
| Sub-Total of Current Liabilities |
8,101,481,816.60 |
| Long-term Loans |
596,503,316.79 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
77,798,247.81 |
| Deferred Income Tax Liabilities |
277,521,651.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,277,083,908.05 |
| Total Liabilities |
9,378,565,724.65 |
| Paid-In Capital(Or Share Stock) |
2,141,567,428.00 |
| Capital Surplus |
42,066,362.08 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
439,640,067.87 |
| Undistributed Profits |
4,636,060,509.17 |
| Minority Stockholder's Interest |
2,379,552,650.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,298,267,400.70 |
| Owner's Equity（Stockholder's Equity） |
8,677,820,051.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,056,385,776.22 |
